The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead ...

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...

Andy Gissing, 62, from Portsmouth, Hampshire, is now trying to fund privately a 'last hope' treatment - and that without it ...

Uncertain about how you can stay healthy on a tight budget, especially when bombarded with misinformation from social media ...

Investing.com -- CG Oncology Inc (NASDAQ:CGON) stock surged 18.1% on Friday after the company announced it expects to deliver topline data from its Phase 3 PIVOT-006 clinical trial nearly a year ahead ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

After all those holiday indulgences, many people feel the need to hit the “reset” button with a detox or cleanse for a ...

The host, 86-year-old Teri Teramoto, moves a plate half an inch to the left, adjusts a bowl, checks the steam rising from her ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...